In the present study, we found that STYX was highly expressed in GC tissues compared with the adjacent non-tumor tissues and the high expression level of STYX was significantly associated with poorer 5-year OS (Overall survival) in the GC patients. The gene discussed is STYX; the disease is gastric cancer.